Friday, September 5, 2008 - 9:44PM EST

Stem Cell Transplantation

1. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.

Author
Schmid C; Labopin M; Nagler A; Bornhauser M; Finke J; Fassas A; Volin L; Gurman G; Maertens J; Bordigoni P; Holler E; Ehninger G; Polge E; Gorin NC; Kolb HJ; Rocha V;
Institution
Department of Medicine II, Klinikum Augsburg, Ludwig Maximilians University of Munich, Augsburg, Germany. christoph.schmid@2med.zk.augsburg-med.de
Journal
J Clin Oncol. 2007 Nov 1;25(31):4938-45. Epub 2007 Oct 1.
Abstract URL
Click here to view abstract

2. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.

Author
Oran B; Giralt S; Couriel D; Hosing C; Shpall EJ; de Meis E; Khouri IF; Qazilbash M; Anderlini P; Kebriaei P; Popat U; Carrasco-Yalan A; Champlin RE; de Lima M;
Institution
Journal
Leukemia. 2007 Dec;21(12):2540-4. Epub 2007 Jul 5.

3. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.

Author
Grigg AP; Gibson J; Bardy PG; Reynolds J; Shuttleworth P; Koelmeyer RL; Szer J; Roberts AW; To LB; Kennedy G; Bradstock KF;
Institution
Department of Clinical Haematology and Bone Marrow Transplant Service, Royal Melbourne Hospital, Melbourne, Australia.
Journal
Biol Blood Marrow Transplant. 2007 May;13(5):560-7. Epub 2007 Feb 22.
Abstract URL
Click here to view abstract

4. Equivalent Survival for Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.

Author
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A;
Institution
Haematology Department, St. Vincent's Hospital, Darlinghurst, NSW, Australia.
Journal
Biol Blood Marrow Transplant. 2007 May;13(5):601-607. Epub 2007 Mar 23.
Abstract URL
Click here to view abstract

5. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.

Author
Perkins JL; Kunin-Batson AS; Youngren NM; Ness KK; Ulrich KJ; Hansen MJ; Petryk A; Steinberger J; Anderson FS; Baker KS; Perkins JL; Kunin-Batson AS; Youngren NM; Ness KK; Ulrich KJ; Hansen MJ; Petryk A; Steinberger J; Anderson FS; Baker KS;
Institution
Department of Pediatric Hematology/Oncology, Children's Hospitals and Clinics, Minneapolis, Minnesota 55404, USA. joanna.perkins@children.org
Journal
Pediatr Blood Cancer. 2007 Dec;49(7):958-63.
Abstract URL
Click here to view abstract

6. Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.

Author
Chang C; Storer BE; Scott BL; Bryant EM; Shulman HM; Flowers ME; Sandmaier BM; Witherspoon RP; Nash RA; Sanders JE; Bedalov A; Hansen JA; Clurman BE; Storb R; Appelbaum FR; Deeg HJ; Chang C; Storer BE; Scott BL; Bryant EM; Shulman HM; Flowers ME; Sandmaier BM; Witherspoon RP; Nash RA; Sanders JE; Bedalov A; Hansen JA; Clurman BE; Storb R; Appelbaum FR; Deeg HJ; Chang C; Storer BE; Scott BL; Bryant EM; Shulman HM; Flowers ME; Sandmaier BM; Witherspoon RP; Nash RA; Sanders JE; Bedalov A; Hansen JA; Clurman BE; Storb R; Appelbaum FR; Deeg HJ;
Institution
Department of Hematology, Shanghai Sixth People's Hospital, Shanghai JiaoTong University, Shanghai, People's Republic of China.
Journal
Blood. 2007 Aug 15;110(4):1379-87. Epub 2007 May 8.
Abstract URL
Click here to view abstract

7. Repeated relapses of acute myelogenous leukemia in the isolated extramedullary sites following allogeneic bone marrow transplantations.

Author
Kikushige Y; Takase K; Sata K; Aoki K; Numata A; Miyamoto T; Fukuda T; Gondo H; Harada M; Nagafuji K;
Institution
Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka.
Journal
Intern Med. 2007;46(13):1011-4. Epub 2007 Jul 2.
Abstract URL
Click here to view abstract

8. Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute myeloid leukemia.

Author
Cho BS; Kim HJ; Lee S; Eom KS; Min WS; Lee JW; Kim CC;
Institution
Division of Hematology, Department of Internal Medicine, Catholic Hemopoietic Stem Cell Transplantation Center, Catholic University of Korea College of Medicine, Seoul, Korea.
Journal
Eur J Haematol. 2007 Aug;79(2):170-3. Epub 2007 Jun 28.
Abstract URL
Click here to view abstract

9. Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission.

Author
Martino R; Valcarcel D; Brunet S; Sureda A; Sierra J;
Institution
Division of Clinical Hematology, Hospital de la Sant Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain. rmartino@santpau.es
Journal
Bone Marrow Transplant. 2008 Jan;41(1):33-8. Epub 2007 Nov 5.
Abstract URL
Click here to view abstract

10. Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes.

Author
Shimoni A; Hardan I; Shem-Tov N; Rand A; Yerushalmi R; Nagler A;
Institution
The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel. ashimoni@sheba.health.gov.il
Journal
Leuk Lymphoma. 2007 Dec;48(12):2352-9.
Abstract URL
Click here to view abstract
Pages: 1 2